Home/Filings/4/0001209191-05-052708

4//SEC Filing

ALTA EMBARCADERO PARTNERS III LLC 4

Accession 0001209191-05-052708

CIK 0001138812other

View on SEC.gov Company Profile

Filed

Oct 17, 8:00 PM ET

Accepted

Oct 18, 1:27 PM ET

Size

22.5 KB

Accession

0001209191-05-052708

Insider Transaction Report

Form 4

Period: 2005-10-14

COTHERIX INCCTRX

ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG

10% Owner

Transactions

Sale
Common Stock
2005-10-14$13.00/sh−10,268$133,484→ 58,370 total(indirect: See footnotes)
Sale
Common Stock
2005-10-14$13.00/sh−152,900$1,987,700→ 869,164 total(indirect: See footnotes)
Sale
Common Stock
2005-10-14$13.00/sh−3,769$48,997→ 21,415 total(indirect: See footnotes)

Holdings

Common Stock
(indirect: See footnote)
2,301,037
Common Stock
(indirect: See footnote)
62,226

ALTA CALIFORNIA PARTNERS III LP

10% Owner

Transactions

Sale
Common Stock
2005-10-14$13.00/sh−10,268$133,484→ 58,370 total(indirect: See footnotes)
Sale
Common Stock
2005-10-14$13.00/sh−3,769$48,997→ 21,415 total(indirect: See footnotes)
Sale
Common Stock
2005-10-14$13.00/sh−152,900$1,987,700→ 869,164 total(indirect: See footnotes)

Holdings

Common Stock
(indirect: See footnote)
2,301,037
Common Stock
(indirect: See footnote)
62,226

ALTA CALIFORNIA MANAGEMENT PARTNERS III LLC

10% Owner

Transactions

Sale
Common Stock
2005-10-14$13.00/sh−3,769$48,997→ 21,415 total(indirect: See footnotes)
Sale
Common Stock
2005-10-14$13.00/sh−152,900$1,987,700→ 869,164 total(indirect: See footnotes)
Sale
Common Stock
2005-10-14$13.00/sh−10,268$133,484→ 58,370 total(indirect: See footnotes)

Holdings

Common Stock
(indirect: See footnote)
62,226
Common Stock
(indirect: See footnote)
2,301,037

JANNEY DANIEL

Director10% Owner

Transactions

Sale
Common Stock
2005-10-14$13.00/sh−152,900$1,987,700→ 869,164 total(indirect: See footnotes)
Sale
Common Stock
2005-10-14$13.00/sh−10,268$133,484→ 58,370 total(indirect: See footnotes)
Sale
Common Stock
2005-10-14$13.00/sh−3,769$48,997→ 21,415 total(indirect: See footnotes)

Holdings

Common Stock
(indirect: See footnote)
2,301,037
Common Stock
(indirect: See footnote)
62,226

ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC

10% Owner

Transactions

Sale
Common Stock
2005-10-14$13.00/sh−3,769$48,997→ 21,415 total(indirect: See footnotes)
Sale
Common Stock
2005-10-14$13.00/sh−152,900$1,987,700→ 869,164 total(indirect: See footnotes)
Sale
Common Stock
2005-10-14$13.00/sh−10,268$133,484→ 58,370 total(indirect: See footnotes)

Holdings

Common Stock
(indirect: See footnote)
62,226
Common Stock
(indirect: See footnote)
2,301,037

ALTA EMBARCADERO PARTNERS III LLC

10% Owner

Transactions

Sale
Common Stock
2005-10-14$13.00/sh−152,900$1,987,700→ 869,164 total(indirect: See footnotes)
Sale
Common Stock
2005-10-14$13.00/sh−10,268$133,484→ 58,370 total(indirect: See footnotes)
Sale
Common Stock
2005-10-14$13.00/sh−3,769$48,997→ 21,415 total(indirect: See footnotes)

Holdings

Common Stock
(indirect: See footnote)
2,301,037
Common Stock
(indirect: See footnote)
62,226

ALTA BIOPHARMA MANAGEMENT III LLC

10% Owner

Transactions

Sale
Common Stock
2005-10-14$13.00/sh−3,769$48,997→ 21,415 total(indirect: See footnotes)
Sale
Common Stock
2005-10-14$13.00/sh−10,268$133,484→ 58,370 total(indirect: See footnotes)
Sale
Common Stock
2005-10-14$13.00/sh−152,900$1,987,700→ 869,164 total(indirect: See footnotes)

Holdings

Common Stock
(indirect: See footnote)
62,226
Common Stock
(indirect: See footnote)
2,301,037

Footnotes (8)

[F1]Not applicable
[F2]Alta BioPharma Partners III, L.P. sold 152,900 shares of Common Stock at the Issuer's Follow-on Public Offering at $13.00/sh for a total of $1,987.700.00
[F3]Daniel Janney, Director, is a managing director of Alta California Managment Partners III, LLC ("ACMPIII") (which is the general partner ("gp") of Alta California Partners III, L.P. ("ACPIII")) & a manager of Alta Embarcadero Partners III, LLC ("AEPIII"). As a managing director & manager of such funds, he may be deemed to share voting & investment powers over the shares held by ACPIII & AEPIII. He is a member of Alta BioPharma Management III, LLC ("ABPMIII") with no voting or investment powers over the shares held by Alta BioPharma Partners III, L.P. ("ABPIII"). He disclaims ownership of all such shares held by all the foregoing funds except to the extent of their proportionate pecuniary interests therein.
[F4]Alta Partners II, Inc. & Alta Partners III, Inc. provide investment advisory services to several funds including ACPIII, AEPIII, ABPIII, Alta BioPharma Partners III GmbH & Co. Beteilgungs KG ("ABPIIIKG")& Alta Embarcadero BioPharma Partners III, LLC ("AEBPIII"). The managing directors ("md") of ABMPIII (which is the gp of ABPIII & ABPIIIKG)& managers of AEBPIII, exercise sole voting & investment powers with respect to the shares ("sh")owned by such funds. G Gruener, G Nohra & D Janney (collectively known as the "principals") are md of ACMPIII & managers of AEPIII. J. Deleage,F.Champsi,A. Marduel,E. Hurwitz & E. Penhoet (collectively known as the "principals") are directors of ABMPIII (which is the gp of ABPIII & ABPIIIKG)& managers of AEBPIII. The principals may be deemed to share voting & investment powers over the sh held by the funds. The principals disclaim beneficial ownership of all such sh held by the funds, except to the extent of their porportionate pecuniary interest therein.
[F5]Alta BioPharma Partners III GmbH & Co. Beteiligungs KG sold 10,268 shares of Common Stock at the Issuer's Follow-on Public Offering at $13.00/sh for $133,484.00.
[F6]Alta Embarcadero BioPharma Partners III, LLC sold 3,769 shares of Common Stock at the Issuer's Follow-on Public Offering for $13.00/sh for a total of $48,997.00.
[F7]Alta California Partners III, L.P. holds 2,301,037 shares of Common Stock.
[F8]Alta Embarcadero Partners III, LLC holds 62,226 shares of Common Stock.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

COTHERIX INC

CIK 0001138812

→

Entity typeother

Related Parties

filerCIK 0001163150

Filing Metadata

Form type: 4
Filed: Oct 17, 8:00 PM ET
Accepted: Oct 18, 1:27 PM ET
Size: 22.5 KB

View on SEC.gov